ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer

September 12, 2014

Fox Chase Publishes Its Cancer Survival Data

February 4, 2011

Columbia Formally Names As 21st Comprehensive Center

March 9, 1979

Normal Routines Dramatically Altered In Days Since Sept. 11 Terrorist Attacks.

September 21, 2001

ACS names new officers.

December 5, 2003

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991